ArticleChirality2026
A Convenient Strategy to Access Diverse Libraries of Amphiphilic Compounds Based on Glycopeptoids.
Article in Chirality, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
A convergent synthetic approach has been developed to access a potentially wide library of amphiphilic glycopeptoids. The intrinsic modularity of apolar peptoid units, coupled with the ability to conjugate various two-headed monosaccharide units, enables the exploration of a vast chemical space for the precise regulation of amphiphilic properties and the formation of diverse nanomaterials through self-assembly. A full characterization of the physical and chemical properties of the self-assembled materials obtained has been conducted on some representative molecular structures designed for the formation of aggregates. The comprehension of the relation between the molecular structure of this family of amphiphilic compounds and their self-assembly could lead to the "on demand synthesis" of functional excipient for drug delivery or compounds for the stabilization and crystallization of membrane proteins.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.